Clinical Trials Sponsored by Dana-Farber/Brigham and Women's Cancer Center
Total 568 results
-
Brigham and Women's HospitalNational Cancer Institute (NCI); Dana-Farber/Brigham and Women's Cancer CenterCompletedAdenoma of Large Intestine
-
Dana-Farber/Brigham and Women's Cancer CenterNational Cancer Institute (NCI)UnknownPrecancerous ConditionUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedMalignant Pleural Mesothelioma | Pleural MesotheliomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Pleural Mesothelioma | Pleural MesotheliomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedHodgkin's DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMultiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALLUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedAcute Myelogenous Leukemia | MyelodysplasiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Tumors | Subcutaneous Tumors | Lymph Node TumorsUnited States
-
Brigham and Women's HospitalDana-Farber Cancer InstituteNot yet recruitingFebrile Neutropenia | Hematologic Malignancy | Antibiotic Stewardship
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalActive, not recruitingGynecologic CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalActive, not recruitingHodgkin's DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedRefractory Acute Myeloid Leukemia | Myelodysplastic Syndrome RAEB-I or RAEB-II | Refractory CML Myeloid Blast CrisisUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedReduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedLung CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedGraft vs Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Hematologic Malignancies | Hodgkin's Disease | Myelogenous LeukemiaUnited States
-
Brigham and Women's HospitalDana-Farber Cancer InstituteTerminatedOral Chronic Graft-Versus-Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedCervix Cancer | Endometrial Carcinoma | Carcinoma of the UterusUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalRecruiting
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedEsophageal CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedNasopharyngeal CarcinomaUnited States
-
Brigham and Women's HospitalDana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Childhood Central Nervous System NeoplasmUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedHemophilia A | Hemophilia BUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedAdenocarcinoma of Esophagus | Squamous Cell Carcinoma of EsophagusUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedGraft Versus Host Disease | GVHDUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminated
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Pleural Mesothelioma | Pleural MesotheliomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedAcute Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedBreast CancerUnited States
-
Dana-Farber Cancer InstituteSanofi; Brigham and Women's HospitalCompletedSquamous Cell Carcinoma of Head and Neck | Advanced Squamous Cell Carcinoma | SSCHN
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedGraft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedLeiomyosarcomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedT Cell Non-Hodgkin LymphomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalTerminatedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; AmgenCompletedHematologic MalignanciesUnited States